Propanc Biopharma advances preparation for Phase 1b study in up to 50 advanced cancer patients
PPCB•Propanc Biopharma is advancing clinical development preparation for its PRP Phase 1b first-in-human study in up to 50 advanced cancer patients. The final clinical protocol is targeted for early November 2026.
1. Study preparation
Propanc Biopharma said it is advancing preparation for the PRP Phase 1b first-in-human study, which is planned to include up to 50 advanced cancer patients. The final clinical protocol is targeted for early November 2026.
